[Vaccination therapy of melanoma].
Schuler-Thurner
Beatrice
B
Dermatologische Klinik mit Poliklink, Universitätsklinikum Erlangen. beatrice.thurner@derma.imed.uni-erlangen.de
Schuler
Gerold
G
D019496:Cancer Vaccines / Q000008:administration & dosage* / Q000276:immunology; D017326:Clinical Trials, Phase III as Topic; D003713:Dendritic Cells / Q000276:immunology; D006360:Heat-Shock Proteins / Q000276:immunology; D006801:Humans; D007155:Immunologic Factors / Q000276:immunology; D016233:Immunotherapy, Active; D008545:Melanoma / Q000276:immunology / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D009362:Neoplasm Metastasis / Q000628:therapy; D009367:Neoplasm Staging; D012867:Skin / Q000473:pathology; D012878:Skin Neoplasms / Q000276:immunology / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D013997:Time Factors; D014611:Vaccination; D019444:Vaccines, DNA / Q000008:administration & dosage
D019496:Cancer Vaccines; D006360:Heat-Shock Proteins; D007155:Immunologic Factors; D019444:Vaccines, DNA